Annual Total Expenses
$1.49 B
+$252.60 M+20.38%
31 December 2023
Summary:
Neurocrine Biosciences annual total expenses is currently $1.49 billion, with the most recent change of +$252.60 million (+20.38%) on 31 December 2023. During the last 3 years, it has risen by +$773.90 million (+107.73%). NBIX annual total expenses is now at all-time high.NBIX Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$437.30 M
-$5.00 M-1.13%
30 September 2024
Summary:
Neurocrine Biosciences quarterly total expenses is currently $437.30 million, with the most recent change of -$5.00 million (-1.13%) on 30 September 2024. Over the past year, it has increased by +$79.70 million (+22.29%). NBIX quarterly total expenses is now -1.13% below its all-time high of $442.30 million, reached on 30 June 2024.NBIX Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBIX Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +20.4% | +22.3% |
| 3 y3 years | +107.7% | +73.9% |
| 5 y5 years | +264.3% | +231.3% |
NBIX Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +107.7% | -1.1% | +76.3% |
| 5 y | 5 years | at high | +264.3% | -1.1% | +231.3% |
| alltime | all time | at high | +9055.2% | -1.1% | >+9999.0% |
Neurocrine Biosciences Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $437.30 M(-1.1%) |
| June 2024 | - | $442.30 M(+7.9%) |
| Mar 2024 | - | $410.00 M(+12.4%) |
| Dec 2023 | $1.49 B(+20.4%) | $364.90 M(+2.0%) |
| Sept 2023 | - | $357.60 M(-5.7%) |
| June 2023 | - | $379.10 M(-3.0%) |
| Mar 2023 | - | $390.70 M(+26.6%) |
| Dec 2022 | $1.24 B(+33.9%) | $308.60 M(+2.8%) |
| Sept 2022 | - | $300.10 M(-7.2%) |
| June 2022 | - | $323.50 M(+5.2%) |
| Mar 2022 | - | $307.50 M(+24.0%) |
| Dec 2021 | $925.70 M(+28.9%) | $248.00 M(-1.4%) |
| Sept 2021 | - | $251.50 M(+13.7%) |
| June 2021 | - | $221.10 M(+7.8%) |
| Mar 2021 | - | $205.10 M(+16.5%) |
| Dec 2020 | $718.40 M(+27.9%) | $176.10 M(-4.4%) |
| Sept 2020 | - | $184.30 M(+2.5%) |
| June 2020 | - | $179.80 M(+0.9%) |
| Mar 2020 | - | $178.20 M(+12.0%) |
| Dec 2019 | $561.50 M(+37.1%) | $159.10 M(+20.5%) |
| Sept 2019 | - | $132.00 M(-8.4%) |
| June 2019 | - | $144.10 M(+14.1%) |
| Mar 2019 | - | $126.30 M(+20.4%) |
| Dec 2018 | $409.60 M(+55.7%) | $104.88 M(+7.6%) |
| Sept 2018 | - | $97.43 M(-1.3%) |
| June 2018 | - | $98.76 M(-9.0%) |
| Mar 2018 | - | $108.53 M(+106.0%) |
| Dec 2017 | $262.99 M(+62.0%) | $52.68 M(-21.1%) |
| Sept 2017 | - | $66.77 M(+5.0%) |
| June 2017 | - | $63.60 M(-20.4%) |
| Mar 2017 | - | $79.93 M(+72.8%) |
| Dec 2016 | $162.37 M(+42.5%) | $46.25 M(+20.3%) |
| Sept 2016 | - | $38.44 M(-8.1%) |
| June 2016 | - | $41.83 M(+16.7%) |
| Mar 2016 | - | $35.86 M(+16.6%) |
| Dec 2015 | $113.97 M(+76.9%) | $30.75 M(-14.2%) |
| Sept 2015 | - | $35.84 M(+41.6%) |
| June 2015 | - | $25.32 M(+14.8%) |
| Mar 2015 | - | $22.06 M(+7.8%) |
| Dec 2014 | $64.41 M(+22.5%) | $20.47 M(+21.4%) |
| Sept 2014 | - | $16.86 M(+17.4%) |
| June 2014 | - | $14.36 M(+12.9%) |
| Mar 2014 | - | $12.72 M(+3.8%) |
| Dec 2013 | $52.60 M(+1.8%) | $12.26 M(-3.7%) |
| Sept 2013 | - | $12.73 M(-8.4%) |
| June 2013 | - | $13.90 M(+1.4%) |
| Mar 2013 | - | $13.71 M(+2.5%) |
| Dec 2012 | $51.69 M(+18.9%) | $13.37 M(+0.3%) |
| Sept 2012 | - | $13.32 M(+11.5%) |
| June 2012 | - | $11.95 M(-8.5%) |
| Mar 2012 | - | $13.06 M(+22.5%) |
| Dec 2011 | $43.49 M(-7.9%) | $10.66 M(-4.7%) |
| Sept 2011 | - | $11.19 M(+1.2%) |
| June 2011 | - | $11.06 M(+4.6%) |
| Mar 2011 | - | $10.57 M(-23.3%) |
| Dec 2010 | $47.22 M | $13.79 M(+15.1%) |
| Sept 2010 | - | $11.98 M(+13.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2010 | - | $10.53 M(-3.6%) |
| Mar 2010 | - | $10.92 M(-16.1%) |
| Dec 2009 | $54.07 M(-39.4%) | $13.02 M(+25.6%) |
| Sept 2009 | - | $10.37 M(-33.7%) |
| June 2009 | - | $15.63 M(+3.9%) |
| Mar 2009 | - | $15.04 M(-48.8%) |
| Dec 2008 | $89.22 M(-58.2%) | $29.39 M(+78.5%) |
| Sept 2008 | - | $16.46 M(-21.0%) |
| June 2008 | - | $20.85 M(-7.4%) |
| Mar 2008 | - | $22.51 M(-82.6%) |
| Dec 2007 | $213.47 M(+39.9%) | $129.13 M(+339.7%) |
| Sept 2007 | - | $29.37 M(+6.4%) |
| June 2007 | - | $27.60 M(+0.8%) |
| Mar 2007 | - | $27.38 M(+6.5%) |
| Dec 2006 | $152.55 M(+2.4%) | $25.70 M(-37.7%) |
| Sept 2006 | - | $41.27 M(+7.2%) |
| June 2006 | - | $38.51 M(-18.2%) |
| Mar 2006 | - | $47.07 M(+21.6%) |
| Dec 2005 | $148.96 M(+8.3%) | $38.70 M(-2.3%) |
| Sept 2005 | - | $39.62 M(+0.5%) |
| June 2005 | - | $39.42 M(+26.3%) |
| Mar 2005 | - | $31.21 M(-21.3%) |
| Dec 2004 | $137.51 M(-30.5%) | $39.67 M(+5.1%) |
| Sept 2004 | - | $37.73 M(+32.7%) |
| June 2004 | - | $28.44 M(-10.2%) |
| Mar 2004 | - | $31.67 M(-28.8%) |
| Dec 2003 | $197.87 M(+62.6%) | $44.51 M(+3.9%) |
| Sept 2003 | - | $42.83 M(-25.5%) |
| June 2003 | - | $57.46 M(+8.3%) |
| Mar 2003 | - | $53.07 M(+17.5%) |
| Dec 2002 | $121.66 M(+42.9%) | $45.15 M(+64.3%) |
| Sept 2002 | - | $27.48 M(+4.7%) |
| June 2002 | - | $26.25 M(+15.2%) |
| Mar 2002 | - | $22.78 M(-19.3%) |
| Dec 2001 | $85.12 M(+69.6%) | $28.24 M(+38.4%) |
| Sept 2001 | - | $20.40 M(+7.8%) |
| June 2001 | - | $18.92 M(+7.7%) |
| Mar 2001 | - | $17.57 M(+18.3%) |
| Dec 2000 | $50.19 M(+36.8%) | $14.86 M(-1.0%) |
| Sept 2000 | - | $15.01 M(+45.4%) |
| June 2000 | - | $10.32 M(+3.2%) |
| Mar 2000 | - | $10.00 M(+8.7%) |
| Dec 1999 | $36.70 M(+29.2%) | $9.20 M(-9.8%) |
| Sept 1999 | - | $10.20 M(+12.1%) |
| June 1999 | - | $9.10 M(+12.3%) |
| Mar 1999 | - | $8.10 M(-1.2%) |
| Dec 1998 | $28.40 M(+10.9%) | $8.20 M(0.0%) |
| Sept 1998 | - | $8.20 M(+43.9%) |
| June 1998 | - | $5.70 M(-12.3%) |
| Mar 1998 | - | $6.50 M(-13.3%) |
| Dec 1997 | $25.60 M(+57.1%) | $7.50 M(+13.6%) |
| Sept 1997 | - | $6.60 M(+15.8%) |
| June 1997 | - | $5.70 M(0.0%) |
| Mar 1997 | - | $5.70 M(-5.0%) |
| Dec 1996 | $16.30 M | $6.00 M(+62.2%) |
| Sept 1996 | - | $3.70 M(-11.9%) |
| June 1996 | - | $4.20 M(+75.0%) |
| Mar 1996 | - | $2.40 M |
FAQ
- What is Neurocrine Biosciences annual total expenses?
- What is the all time high annual total expenses for Neurocrine Biosciences?
- What is Neurocrine Biosciences annual total expenses year-on-year change?
- What is Neurocrine Biosciences quarterly total expenses?
- What is the all time high quarterly total expenses for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly total expenses year-on-year change?
What is Neurocrine Biosciences annual total expenses?
The current annual total expenses of NBIX is $1.49 B
What is the all time high annual total expenses for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual total expenses is $1.49 B
What is Neurocrine Biosciences annual total expenses year-on-year change?
Over the past year, NBIX annual total expenses has changed by +$252.60 M (+20.38%)
What is Neurocrine Biosciences quarterly total expenses?
The current quarterly total expenses of NBIX is $437.30 M
What is the all time high quarterly total expenses for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly total expenses is $442.30 M
What is Neurocrine Biosciences quarterly total expenses year-on-year change?
Over the past year, NBIX quarterly total expenses has changed by +$79.70 M (+22.29%)